Do You Need a License to Sell Peptides in New Hampshire?

There is no single credential called a "peptide license" — not in New Hampshire, not anywhere. The question actually contains three separate ones: whether your entity is properly registered to do business at all, whether what you are handling falls into a regulated drug or device distribution category that requires product-specific licensure, and whether you are operating in the research-use-only lane, where the controlling factor is how the material is labeled, sold, and represented rather than what molecule is in the vial. Which of those apply to your specific model is a determination for your attorney and the relevant state board — this article describes the questions, not the answers, and it is informational, not legal advice.

The single question that is actually three

Most operators who search this phrase are really asking one of three very different things, and the answer diverges sharply depending on which.

The first is general commercial licensure. Nearly every state expects a business to exist formally before it transacts: an entity registration, a trade name filing if you operate under something other than your legal name, tax account registrations where applicable, and whatever municipal or local requirements attach to your address. This layer has nothing to do with peptides. It applies identically whether you sell research compounds, coffee, or software, and it is the layer most buyers already have handled.

The second is product-category licensure. Certain product classes — prescription drugs, devices, controlled substances, some cosmetics and food categories — carry their own distribution and wholesale requirements administered by state boards of pharmacy or health agencies, layered on top of federal frameworks. Whether a given transaction pulls you into that category is not determined by the word "peptide." It is determined by what the product is represented to be and what it is intended for.

The third is the research-use-only lane, and it is the one most misunderstood. Materials sold and labeled for laboratory research are a distinct commercial category. Staying inside that category is not a passive state — it is a function of your labeling, your marketing copy, your customer terms, and what your staff says on the phone. The lane can be exited accidentally, by a business that never filed anything and never intended to change categories.

What actually moves a product between categories

This is the mechanism worth understanding, because it is where most avoidable exposure comes from. Regulators generally do not evaluate a product in isolation. They look at how it is represented: the label, the packaging, the website copy, the ad targeting, the emails, the instructions given to a buyer, and the context in which it is sold. A material sold for laboratory research and a material sold as something a person will use can be chemically identical and sit in entirely different regulatory categories, because intended use is inferred from the seller's own conduct.

The practical consequence for a reseller, med spa, wellness brand, or telehealth operator is that compliance is not a one-time filing. It is an ongoing discipline over what your business publishes and says. Copy that describes benefits a person would experience, imagery implying personal use, a sales script that answers questions about how someone would take something, a bundled configuration that reads as a ready-to-use kit — each of these is a representation, and representations accumulate. Your supplier's labeling protects you only to the point where your own marketing takes over.

There is a second-order consequence that rarely appears in legal discussions but shows up fast in operations. Payment processors, merchant account underwriters, insurers, advertising platforms, and marketplace hosts run their own category reviews, and they apply their own risk policies independent of any state or federal determination. A business whose public representations blur the research lane frequently encounters a processor freeze or an ad account suspension long before it encounters a regulator. That is a business continuity problem regardless of how the legal question eventually resolves.

The questions to bring to counsel and your state board

Rather than assuming which lane applies, bring a structured set of questions to an attorney who practices in this area and, where relevant, to the applicable licensing board. Do not rely on forum consensus, supplier assurances, or what a competitor appears to be doing — none of those are a determination about your business.

The useful questions sound like this: given exactly how I describe these products, which category does a regulator most plausibly place me in? What documentation would I need to produce if asked to substantiate my supply chain? Does my professional license, if I hold one, change the analysis or merely sit alongside it? What in my current website copy would you change first? A good advisor will ask to see your materials before answering anything — that is the correct response, and it is a signal you have the right advisor.

Documentation is the part you control completely

Whatever lane you land in, the record you keep is entirely within your control and is usually the difference between a routine inquiry and a prolonged one. Build the file before anyone asks for it.

Start with supplier qualification. Keep a written record of who you buy from, what testing they perform, and how you verified it — not a screenshot, but a durable record tied to specific lots. Keep batch-specific certificates of analysis matched to the lots you actually received, not a generic document representing a product line. Lot traceability is the backbone of the whole file: if you cannot connect a shipment you sent out to a specific incoming lot and its testing record, you have no substantiation story.

Next, keep your representations under version control. Save what your website said and when. Save your email templates, your product descriptions, your labels, and your customer-facing terms. If counsel revises your copy, keep the before and after. Businesses that cannot reconstruct what they published two years ago are in a poor position to demonstrate consistent conduct.

Finally, keep your customer terms enforced rather than merely posted. Terms that a buyer must affirmatively accept, that state the research-use-only nature of the material, and that are consistently applied across channels are more meaningful than boilerplate buried in a footer. None of this is a substitute for legal advice — it is the evidentiary base your counsel will need in order to give you good advice at all.

Supplier diligence: what to verify before you stock anything

Your supplier does not carry your compliance obligations, but a weak supplier makes every one of them harder. Evaluate on evidence you can independently check.

Ask for batch-specific certificates of analysis and confirm the lot number on the document matches the vial in your hand. Ask whether purity is established by HPLC and whether identity is separately confirmed — purity and identity are different questions, and a document that answers only one is incomplete. Ask what else is screened beyond purity and identity, because contamination and residual-solvent panels are where quality programs actually differentiate.

Then watch for the practices that should end the conversation. COAs available only after purchase, or sold as a paid add-on, tell you the testing is a revenue line rather than a standard. Pricing that requires a phone call at every tier makes cost modeling impossible and tends to move with the buyer rather than the volume. Testing described as "third-party verified" without a document you can read is an assertion, not evidence. Fulfillment timelines that cannot be stated plainly become your stockouts. And a supplier that will not put terms in writing is a supplier whose terms can change after you have committed.

Run this diligence before your first order, not after your first problem. Switching suppliers mid-catalog is expensive in ways that show up as lot inconsistency and customer questions you cannot answer.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for businesses that need the diligence above to be simple rather than adversarial. Compounds are supplied for laboratory research use only and are not FDA-approved drugs; they are never sold or described as products for human consumption.

Purity is specified at 99%+ by HPLC. Every batch runs through a multi-panel testing protocol covering identity, purity, and contaminant screening, and the resulting certificates of analysis are published for public verification — a partner or a partner's own customer can read the lab results without requesting them, paying for them, or taking anyone's word about what they say. That single practice removes the most common failure point in supplier diligence, because verification does not depend on the supplier's cooperation.

Fulfillment is handled domestically, with orders shipping in five to seven days, which makes inventory planning a schedule rather than a guess. Wholesale pricing is structured by tier rather than negotiated case by case. The catalog spans the categories most partners build around, including the popular research compounds collection alongside widely studied single compounds such as BPC-157 and GHK-Cu, where the published research is discussed honestly as research rather than as a promise.

The application itself is three steps: submit your business information, complete verification, and receive tier pricing. No discovery calls before you can see a price sheet.

Where this leaves a qualified buyer

If your entity is properly registered, your counsel has reviewed how you represent these materials, and you are prepared to keep the documentation described above, the remaining decision is which supplier gives you verifiable evidence instead of assurances. Businesses at that stage can apply to the Wholesale Partner Program and get tier pricing without a gated sales process — the qualification is about your business being real and your positioning being sound, not about how large your first order is.

More on the program structure and the qualification path is available on the wholesale peptides program page, with a broader breakdown of the licensing landscape at do you need a license to sell peptides, and businesses ready to move can apply for a wholesale account directly.